AMIDOAROMATIC RING SULFONAMIDE HYDROXAMIC ACID COMPOUNDS
申请人:MONSANTO COMPANY
公开号:EP0983267A1
公开(公告)日:2000-03-08
US6451791B1
申请人:——
公开号:US6451791B1
公开(公告)日:2002-09-17
[EN] AMIDOAROMATIC RING SULFONAMIDE HYDROXAMIC ACID COMPOUNDS<br/>[FR] COMPOSES D'ACIDE HYDROXAMIQUE SULFONAMIDE A CYCLE AMIDOAROMATIQUE
申请人:——
公开号:WO1998039329A1
公开(公告)日:1998-09-11
[EN] An amidoaromatic ring sulfonamide hydroxamic acid compound that inter alia inhibits matrix metalloprotease activity is disclosed, as are a treatment process that comprises administering a contemplated amidoaromatic ring sulfonamide hydroxamic acid compound in an MMP enzyme-inhibiting effective amount to a host having a condition associated with pathological matrix metalloprotease activity. [FR] La présente invention concerne un composé d'acide hydroxamique sulfonamide à cycle amidoaromatique qui inhibe notamment une activité de métalloprotéase matricielle (MMP). La présente invention concerne également un procédé de traitement qui consiste à administrer le composé d'acide hydroxamique sulfonamide à cycle amidoaromatique en question, à raison d'une quantité efficace destinée à inhiber l'activité d'un enzyme MMP, à un hôte présentant un état associé à l'activité pathologique de métalloprotéase matricielle.
Amidoaromatic ring sulfonamide hydroxamic acid compounds
申请人:Monsanto Company
公开号:US06451791B1
公开(公告)日:2002-09-17
An amidoaromatic ring sulfonamide hydroxamic acid compound that inter alia inhibits matrix metalloprotease activity is disclosed, as are a treatment process that comprises administering a contemplated amidoaromatic ring sulfonamide hydroxamic acid compound in a MMP enzyme-inhibiting effective amount to a host having a condition associated with pathological matrix metalloprotease activity.